Skip to main content
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
Online First
Case Reports, Leukemia
Successful Treatment of Chronic Myeloid Leukemia with Low-Dose Nilotinib
Eric Haigh, BS, Kamran Darabi, MD
Read More
FDA Updates
Actemra First FDA-Approved Treatment for CAR T-Cell–Induced Severe Cytokine Release Syndrome
Read More
FDA Updates
Mylotarg Now Approved for the Treatment of Patients with CD33-Positive AML
Read More
FDA Updates
Nivolumab Receives New Indication for dMMR and MSI-H Metastatic Colorectal Cancer
Read More
FDA Updates
Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL
Read More
FDA Updates
Kymriah First Gene Therapy Approved by the FDA, Indicated for Young Patients with B-Cell ALL and CD19
Read More
Survey End Page
Read More
Supplements
Uridine Triacetate: An Antidote to Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
Wen Wee Ma, MBBS
Read More
Supplements
Serious Toxicities Associated with 5-Fluorouracil and Capecitabine: A Clinical Pharmacy Perspective
Amber Draper, PharmD, BCOP
Read More
Page 163 of 197
Results 1621 - 1630 of 1969